logo image
search icon
date background image

Jul 09, 2024

Patient Recruitment and Retention Services Market Set for Explosive Growth: New Report Forecasts 5% CAGR to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Patient Recruitment and Retention Services Market Size, Share & Trends Analysis Report By Type (Patient Recruitment Services, Patient Retention Services), By Disease Indication, By Trial Phases, By Age Group, By End-User, - Market Outlook And Industry Analysis 2031"


The Global Patient Recruitment and Retention Services Market is valued at US$ 3,870.3 Mn in 2023, and it is expected to reach US$ 5,700.0 Mn by 2031, with a CAGR of 5.00% during the forecast period of 2024-2031.


Request Complete FREE Sample Report Click Here: https://www.insightaceanalytic.com/request-sample/1335


Patient recruitment and retention services (PRRS) are specialized services provided by various organizations, often in the healthcare and clinical research industries, to ensure that clinical trials and other medical studies have sufficient participants and that these participants remain engaged throughout the study. These services are designed to help sponsors, research institutions, and clinical trial sites overcome the challenges of finding the right participants and keeping them engaged throughout the study. By employing a variety of strategies, patient recruitment and retention specialists can significantly improve the efficiency and success of clinical trials. 


Patient recruitment and retention specialists can foster clear communication between patients and researchers, ensuring participants are well-informed and engaged throughout the study. Patient recruitment involves identifying, contacting, and enrolling eligible participants for clinical trials. This process can be challenging due to strict eligibility criteria, patient willingness, and awareness of the trial. Ensuring all recruitment and retention activities comply with regulatory standards and ethical guidelines is paramount.


Effective patient recruitment and retention are essential for the success of clinical trials. They ensure that studies are adequately powered to detect treatment effects, reduce the time to study completion and improve the generalizability of the study results. Additionally, a positive patient experience can enhance the reputation of the research organization and encourage future participation in studies.


List of Prominent Players in the Patient Recruitment and Retention Services Market:

  • Acurian
  • BBK Worldwide
  • Bright Pharmaceutical Services
  • Elligo Health Research
  • CSSi
  • Clinical Trial Media
  • Evolution Research Group (ERG)
  • Integrated Clinical Trial Services (ICTS)
  • MMG
  • Veristat
  • Altasciences Clinical Los Angeles Inc.
  • Antidote
  • Clinical Accelerator
  • Fidelis Research
  • Ignite Data
  • Polaris BioPharma Consulting
  • Clinrol
  • TrialWire Platform
  • Other Prominent Players


Market Dynamics:



A driver of patient recruitment and retention services is adopting a patient-centric approach that prioritizes patient engagement and education. This involves providing potential participants with comprehensive information about the trial, including its purpose, procedures, potential risks, and benefits. Ensuring that patients are well-informed helps build trust and transparency. Additionally, collaborating with patient advocacy organizations plays a vital role in building trust and credibility. This collaborative approach not only improves patient recruitment and retention rates but also contributes to more successful and ethical clinical trials. 

Another key driver of patient recruitment and retention services is the thoughtful design of study protocols that minimize patient burden. This includes reducing the number of required visits and simplifying procedures, making participation more convenient and less time-consuming for patients. Additionally, employing adaptive trial designs is crucial. These designs allow modifications based on interim results, which can improve the study's efficiency and responsiveness to patient needs. Adaptive trials can adjust various aspects of the study, such as dosing, sample size, or treatment regimens, in response to ongoing data.



Complex clinical trial designs make it harder to recruit and retain patients. Stringent eligibility criteria, long hospital visits, and frequent check-ups become burdens for patients and families, especially in pediatric trials.


Regional Trends:

North America dominates the market. Access to advanced medical facilities and technology facilitates recruitment efforts but can also lead to higher participant expectations. Strict regulatory frameworks such as FDA regulations in the United States necessitate thorough compliance and rigorous patient recruitment strategies. Asia Pacific is the fastest-growing region due to increasing investment in healthcare and clinical research in countries like China and India fuels a growing pool of potential participants.


Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1335


Recent Developments:

  • In Feb 2024, BBK Worldwide (BBK), attended the Orlando Summit for Clinical Ops Executives (SCOPE). Social media influencers have developed into creative community brokers that may be used to increase patient acquisition, especially for demographics that are difficult to reach. A case study demonstrating the effective use of influencer marketing to persuade patient audiences to participate in clinical trials will be presented during the session.
  • In Aug 2023, BBK Worldwide (BBK), declared the release of VISION, a technology-enabled solution that gives sponsors of clinical trials the knowledge and insights they need to make smart decisions in an enrollment environment that is getting more and more complex. A recent addition to BBK's TCN Engage suite of enrollment products and services is VISION.


Segmentation of Patient Recruitment and Retention Services Market-


By Type

  • Patient Recruitment Services
  • Patient Retention Services


By Disease Indication

  • Oncology
  • Infectious Disease
  • Cardiovascular Disease
  • CNS/Neurology
  • Endocrine/Metabolic
  • Hematological Disorders
  • Others


By Trial Phases

  • Phase I
  • Phase II
  • Phase III
  • Phase IV


By Age Group

  • Pediatric
  • Adult
  • Geriatrics


By End User

  • Hospitals
  • CROs
  • Pharma and Biotech Companies
  • Others


By Region


North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa